Globe Newswire (Tue, 24-Feb 8:00 AM ET)
Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Benzinga (Tue, 24-Feb 5:21 AM ET)
Globe Newswire (Tue, 23-Dec 9:00 AM ET)
Globe Newswire (Wed, 3-Dec 8:30 AM ET)
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Artelo Biosciences trades on the NASDAQ stock market under the symbol ARTL.
As of February 25, 2026, ARTL stock price declined to $1.21 with 8,709 million shares trading.
ARTL has a beta of 0.79, meaning it tends to be less sensitive to market movements. ARTL has a correlation of 0.01 to the broad based SPY ETF.
ARTL has a market cap of $2.44 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ARTL traded as high as $28.60 and as low as $1.10.
The top ETF exchange traded funds that ARTL belongs to (by Net Assets): VXF.
ARTL has underperformed the market in the last year with a price return of -82.0% while the SPY ETF gained +17.3%. ARTL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -32.0% and -16.0%, respectively, while the SPY returned +3.9% and +0.1%, respectively.
ARTL support price is $1.20 and resistance is $1.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARTL shares will trade within this expected range on the day.